BUZZ — Australia's AdAlta surges as partner lands up to $120 million cell therapy deal
* Shares of AdAlta rise as much as 33.3% to A$0.0040, marking their biggest intraday pct gain since September 3 * Shares hit their highest level since September 4 * Biotech firm says its cell therapy manufacturing partner Oribiotech has signed a 10-year agreement worth up to US$120 million * Adds, deal will integrate O